Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) last posted its earnings results on Wednesday, May 6th. Zevra Therapeutics had a return on equity of 51.49% and a net margin of 101.58%. On average, analysts expect Zevra Therapeutics to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year. Get Zevra Therapeutics alerts:Zevra Therapeutics Trading Down 1.8%Shares of NASDAQ ZVRA traded down $0.18 during mid-day trading on Wednesday, hitting $9.55. Read MoreReceive News & Ratings for Zevra Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevra Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.